NEW YORK, July 02, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Prothena Corporation (NASDAQ:PRTA)
Lead Plaintiff Deadline: July 16, 2018
Class Period: October 15, 2015 - April 20, 2018
Allegations: Prothena made materially false and/or misleading statements or failed to disclose that: relevant trial data showed that Prothena’s antibody NEOD001, designed to treat amyloid light chain amyloidosis (“AL amyloidosis”), was not an effective treatment; the Company made misleading comparisons of NEOD001’s “best response” rates against certain prior studies; and the Company touted Prothena’s ongoing Phase 1/2 study of NEOD001 as providing a strong basis for late-stage Phase 2b and Phase 3 studies of NEOD001, even though the full Phase 1/2 study data demonstrated that NEOD001 was not an effective treatment.
Get additional information: http://www.kleinstocklaw.com/pslra-c/prothena-corporation-2?wire=3.
PPG Industries, Inc. (NYSE:PPG)
Lead Plaintiff Deadline: July 19, 2018
Class Period: April 24, 2017 - May 10, 2018
Allegations: PPG’s consolidated financial statements for the year ended December 31, 2017 and quarterly financial statements for 2017 contained improper accounting entries and could not be relied upon; PPG failed to maintain adequate internal controls; and as a result, defendants’ public statements were materially false and misleading at all relevant times.
Get additional information: http://www.kleinstocklaw.com/pslra-c/ppg-industries-inc-2?wire=3.
Deutsche Bank Aktiengesellschaft (NYSE:DB)
Lead Plaintiff Deadline: August 6, 2018
Class Period: March 20, 2017 - March 30, 2018
Allegations: Deutsche Bank made materially false and/or misleading statements or failed to disclose that: Deutsche Bank’s internal control environment and infrastructure were materially weak and deficient; and as a result, Deutsche Bank's statements about the Company's business and operations were materially false and misleading at all relevant times.
Get additional information: http://www.kleinstocklaw.com/pslra-c/deutsche-bank-aktiengesellschaft-2?wire=3.
Aegean Marine Petroleum Network Inc. (NYSE:ANW)
Lead Plaintiff Deadline: August 6, 2018
Class Period: April 28, 2016 - June 4, 2018
Allegations: Aegean had improperly accounted for an approximate $200 million of accounts receivable as of December 31, 2017; Aegean failed to maintain effective internal control over financial reporting; and as a result of the foregoing, Defendants’ statements about Aegean’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
Get additional information: http://www.kleinstocklaw.com/pslra-c/aegean-marine-petroleum-network-inc?wire=3.
REV Group, Inc. (NYSE:REVG)
Lead Plaintiff Deadline: August 7, 2018
Class Period: (1) pursuant to the initial public offering on or around January 27, 2017 and/or (2) January 27, 2017 - June 7, 2018
Allegations: the Company was experiencing cost inflation across many of the commodities and services it bought; the Company was experiencing difficulty obtaining the chassis necessary for production; the Company’s margins were being negatively impacted by a lower sales of high margin products; the Company did not have “strong visibility into future net sales” to “effectively plan” and manage its backlog of vehicles; the Company’s manufacturing operations were not operating efficiently or at a low cost to satisfy customer demand; and as a result of the foregoing, Defendants’ statements about REV’s business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis.
Get additional information: http://www.kleinstocklaw.com/pslra-c/rev-group-inc?wire=3.
Ormat Technologies, Inc. (NYSE:ORA)
Lead Plaintiff Deadline: August 8, 2018
Class Period: August 8, 2017 - May 15, 2018
Allegations: Ormat Technologies made materially false and/or misleading statements or failed to disclose that: there were errors in the income tax provision primarily relating to Ormat’s valuation allowance based on its ability to utilize foreign tax credits in the U.S. prior to their expiration; Ormat netted certain deferred income tax assets and deferred income tax liabilities across different tax jurisdictions that are not permitted to be netted pursuant to United States generally accepted accounting principles; Ormat’s internal controls over financial reporting were ineffective; Ormat would need to restate its second, third and fourth quarter 2017 financial statements and its full-year 2017 financial statements; and as a result, defendants’ statements about Ormat’s business, operations and prospects were materially false and misleading and/or lacked a reasonable bases at all relevant times.
Get additional information: http://www.kleinstocklaw.com/pslra-c/ormat-technologies-inc-2?wire=3.
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com